Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001214659-25-009205
Filing Date
2025-06-13
Accepted
2025-06-13 16:19:25
Documents
2
Period of Report
2025-06-13

Document Format Files

Seq Description Document Type Size
1 i6132526k.htm 6-K 12084
2 EXHIBIT 1.1 ex1_1.htm EX-1.1 673393
  Complete submission text file 0001214659-25-009205.txt   686641
Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ
Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ 44 (0)1235 888300
Biodexa Pharmaceuticals Plc (Filer) CIK: 0001643918 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37652 | Film No.: 251046869
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)